269. Metagenomics in Transplantation and Cancer Care
Saturday, October 10, 2015: 2:00 PM-3:30 PM
Room: 30--ABCDE

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • describe the impact of intestinal microbial diversity on infection risk, graft versus host disease and clinical outcomes following hematopoietic stem cell transplantation
  • review what is known about the human virome and how it changes after transplantation
  • assess the potential of microbiome research to advance and inform immunocompromised host clinical practice in the future

Target Audience: Microbiologists, Members-in-training, Lab personnel, Investigators, Infectious diseases physicians, Infectious diseases pediatricians, Healthcare workers, Fellows, Clinicians, Academicians

Tracks: Investigative ID, Adult ID

Moderators:  Kimberly Hanson, MD, MHS, University of Utah School of Medicine and Ami Bhatt, MD, PhD, Broad Institute, Cancer Program

CME Credits: Maximum of 1.5 hours of AMA PRA Category 1 CreditTM

ACPE Credits:

ACPE Number:


K. Hanson, None

A. Bhatt, None

See more of: Symposium

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 7th with the exception of research findings presented at the IDWeek press conferences.